Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIGHT
NCT05294328Phase 2Completed
- Sponsor
- LENZ Therapeutics
- Start
- May 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aceclidine in presbyopia, sponsored by LENZ Therapeutics. Started May 2022; status: completed.
02
Drugs
aceclidine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT05294328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294328.